chr15-66387126-T-TGC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_002755.4(MAP2K1):c.-216_-215dup variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00605 in 371,492 control chromosomes in the GnomAD database, including 50 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 47 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 3 hom. )
Consequence
MAP2K1
NM_002755.4 5_prime_UTR
NM_002755.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.818
Genes affected
MAP2K1 (HGNC:6840): (mitogen-activated protein kinase kinase 1) The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 15-66387126-T-TGC is Benign according to our data. Variant chr15-66387126-T-TGC is described in ClinVar as [Likely_benign]. Clinvar id is 316834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0588 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP2K1 | NM_002755.4 | c.-216_-215dup | 5_prime_UTR_variant | 1/11 | ENST00000307102.10 | NP_002746.1 | ||
MAP2K1 | XM_017022411.3 | c.-216_-215dup | 5_prime_UTR_variant | 1/10 | XP_016877900.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP2K1 | ENST00000307102.10 | c.-216_-215dup | 5_prime_UTR_variant | 1/11 | 1 | NM_002755.4 | ENSP00000302486 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0132 AC: 1858AN: 141064Hom.: 47 Cov.: 33
GnomAD3 genomes
AF:
AC:
1858
AN:
141064
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00168 AC: 387AN: 230294Hom.: 3 Cov.: 2 AF XY: 0.00136 AC XY: 165AN XY: 121652
GnomAD4 exome
AF:
AC:
387
AN:
230294
Hom.:
Cov.:
2
AF XY:
AC XY:
165
AN XY:
121652
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0132 AC: 1862AN: 141198Hom.: 47 Cov.: 33 AF XY: 0.0127 AC XY: 870AN XY: 68568
GnomAD4 genome
AF:
AC:
1862
AN:
141198
Hom.:
Cov.:
33
AF XY:
AC XY:
870
AN XY:
68568
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3474
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cardio-facio-cutaneous syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2018 | - - |
Noonan syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at